|
|
| Press |
|
Aureus Pharma, Gene
IT, Genomining, Genostar, Helios Biosciences
and INRIA will be delighted INRIA - with its partners Opticsvalley,
Génopôle and CEA - will host |
Aureus Pharma headquartered in Paris, France is a privately held knowledge management based solutions provider for the life sciences industry. Aureus Pharma accelerates new drug discovery by providing knowledge databases which contain high quality quantitative information for both chemistry and biology. The information contained in the Aureus Pharma system is of primary importance to aid in lead discovery and optimization as well as to build predictive models.
More information: www.aureus-pharma.com
Gene-IT is a creator and supplier of innovative biological sequence search technology that provides relevant answers to questions about genetic material in the large. These questions are asked by scientists and attorneys today, and will be asked by clinicians and physicians in the future. The company’s flagship product, GenomeQuest, is an easy-to-use Web-based application that integrates, mines and analyzes sequence data from dozens of scientific and patent sources worldwide. Its proprietary sequence analysis capabilities help the world’s leading pharmaceutical and biotechnology companies make faster and more accurate decisions on their gene and protein discoveries. Its automated alerting, report publishing and knowledge-sharing capabilities enhance the productivity of all users.Gene-IT is a privately held U.S. company with headquarters in Westborough, Massachusetts. Our French subsidiary is located in Rueil-Malmaison near Paris, France.
More information: http://www.gene-it.com
Genomining is a Bioinformatics company specialized in the discovery and interpretation of biological data. Genomining provides infrastructure solutions to boost the productivity of research centers of the life sciences industry. Infrastructure solutions leverages the large number of biological data types by allowing to analyse them with the very large number of useful bioinformatics tools that are now made available by other companies. GetDB is a product og Genomining, it allows its users to design workflows that are automatically applied to target databases to produce new knowledge.GetDB has been design to manage easily the wide variety of biological databases available on the internet, produced by a customer or its parteners or obtained from other providers of value added data.
More information: http://www.genomining.com/
Genostar is a bioinformatics software company which mission is to assist biologists in their discovery process. Genostar provides an integrated and interactive bioinformatics software environment, IOGMA, dedicated to genomics and post-genomics. IOGMA is made up of a complete annotation suite which supports comparative genomics and gene-metabolic network analysis and exploration, datamining and advanced gene expression analysis, and qualitative simulation of genetic networks.
More information: http://www.genostar.com/
Helios Biosciences is a Young Innovating Company which selects and validates relevant therapeutic targets. Dynamic mathematical models of molecular interaction networks are built and used to select therapeutic targets. This proprietary technology is very efficient: 70% of the therapeutic targets selected are validated. Helios internal programs are focused on prostate cancer neuro-degenerative diseases. Partnerships with pharmaceutical industry are actively explored on these internal programs as well as on other therapeutic areas (inflammation, other cancers…).
More information: http://www.helios-bioscience.com/
The mission of the French National Institute for Research in Computer
Science and Control is to carry out research in Information and Communication
Sciences and Technologies (ICST). Through six research units located
in seven major regions*,
INRIA employs a workforce of 3,600 people, including 2,800 scientists
(from INRIA and associate organisations). INRIA’s annual budget
is €160 million (excluding VAT), 20% of which comes from its
own resources (contracts, licences). INRIA plays a decisive role
in five areas of research: communicative, cognitive, symbolic, numerical
and biological systems.
INRIA develops many partnerships with industry and fosters technology transfers
and business creation (80 enterprises) in the field of ICST, in particular through
its affiliate, INRIA-Transfert, who operates four seeding funds.
International partnerships involve receiving and recruiting foreign students,
as well as numerous exchanges among researchers. Priority is given to geographic
regions with high economic potential: the European Research Area, Asia and North
America, while maintaining basic activity with South America, Africa and the
Middle East.
* Aquitaine, Bretagne, Lorraine, Ile-de-France, Nord Pas
de Calais, Provence Alpes Côte d'Azur and Rhône-Alpes.
More information: http://www.inria.fr
| INRIA Vincent CORONINI Tel.: +33 1 39 63 57 29 |
Stratéus for INRIA Matthias Le Fur Tel: +33 1 40 41 56 66 Clémentine Duguay Tel.: +33 1 40 41 56 11 |
